Cite
APA Citation
Kavanaugh, A., Gladman, D., Edwards, C., Poder, A., Lioté, F., Bird, P., Schett, G., Nguyen, D., Teng, L., & Mease, P. (n.d.). tHU0432 Apremilast, An Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from 3 Phase III, Randomized, Controlled Trials. Annals of the rheumatic diseases, 75, 346. http://access.bl.uk/ark:/81055/vdc_100135166331.0x000055